Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

SYNERGY PHARMACEUTICALS, INC. (SGYP) Class Action Lawsuit (February 2018)

Closed

1:18cv873 • February 8, 2018

Class Period Start

November 10, 2016

Class Period End

November 13, 2017

PSLRA Deadline

April 10, 2018

Case Allegations

10b5

Statutes of Repose

Nov 10, 2019

Country

United States

Court

Federal Court

Docket History

Nov 8, 2023

Voluntary Dismissal

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Oct 28, 2021

On Appeal

Sep 30, 2021

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Jan 28, 2021

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Nov 30, 2020

Second Amended Complaint

A new complaint has been filed on behalf of certain investors in SYNERGY PHARMACEUTICALS, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Sep 16, 2019

Motion to Dismiss Denied

The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.

Dec 6, 2018

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Aug 31, 2018

First Amended Complaint

A new complaint has been filed on behalf of certain investors in SYNERGY PHARMACEUTICALS, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Jun 22, 2018

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Mar 21, 2018

Scheduling Order

Feb 8, 2018

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in SYNERGY PHARMACEUTICALS, INC..

TOP